Afghanistan has faced medicine shortages and rising prices following the suspension of pharmaceutical imports from Pakistan.
Zahed did not provide details about the exact date imports from Iran would begin, the quantities involved or the types of medicines expected to enter Afghanistan.
Speaking on Sunday at the closing ceremony of the second Afghanistan National and International Health Exhibition, he said the implementation of a law aimed at preventing the smuggling of medicines and healthcare products had stopped smuggled and substandard medicines from entering Afghanistan.
The Taliban's announcement of imminent medicine imports from Iran comes after the governor of Iran's South Khorasan province stated in early 2026 that more than 70% of the medicines used in Afghanistan were supplied by Iranian manufacturers.
Abdul Hakim Tamanna, the former head of Herat's Public Health Department, told Afghanistan International that Iranian medicines were of moderate quality and that their quality was acceptable for the Afghan market.
However, he emphasized that in the past, a large proportion of Afghanistan's medicine requirements were supplied by Iran. In subsequent years, however, sanctions and other challenges gradually reduced pharmaceutical imports from the country, while Pakistani, Indian and Turkish medicines gained a larger share of the Afghan market.
Tamanna believes that if Iran has sufficient pharmaceutical production and export capacity to meet the needs of the Afghan market, and reduces bureaucratic obstacles and export restrictions, Iranian medicines could replace some of the medicines previously imported from Pakistan.
On February, the Taliban completely banned pharmaceutical imports from Pakistan and instructed companies to seek alternative routes and suppliers to meet Afghanistan's medical needs.
The decision came despite Pakistan being one of Afghanistan's main suppliers of medicines. According to available figures, more than 70% of the medicines required in Afghanistan had been imported from Pakistan.
Following the implementation of the ban, reports emerged of medicine shortages in several Afghan provinces and rising prices for certain pharmaceutical products.
Pharmacists and patients in Kandahar and Kabul previously told Afghanistan International that access to some essential medicines, including insulin, heart medications, antibiotics and treatments for chronic illnesses, had become more difficult.
Some pharmacies also said the decline in legal pharmaceutical imports from Pakistan had created opportunities for medicines to enter through smuggling routes. Such products could be of poor quality or may have been stored under unsuitable conditions.
Medicine shortages and rising prices have created serious difficulties, particularly for families already facing financial hardship.
Several patients also reported being forced to reduce their use of certain prescribed medicines or postpone treatment because the medicines were either too expensive or unavailable.
Following the ban on pharmaceutical imports from Pakistan, the Taliban have sought alternative sources to meet demand in Afghanistan's pharmaceutical market.
Taliban officials previously announced negotiations with Iran, Russia, India, Türkiye and Uzbekistan over medicine imports.
However, reports indicate that alternative suppliers have so far been unable to fully compensate for the shortfall caused by the suspension of pharmaceutical imports from Pakistan.